Associated Papers
Role of silent mutations in KRAS -mutant tumors.
Lu J et al.
Chinese Medical Journal, 2025
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers.
Kobayashi Y et al.
Nature, 2022
Clinical Implication of KRAS Mutation Variants in Patients With Resected Colon Cancer.
Baek JH et al.
Cancer Diagnosis & Prognosis, 0
Select a paper to view details